Cargando…

Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study

Detalles Bibliográficos
Autores principales:	Foca, A, Peronace, C, Marano, V, Barreca, GS, Lamberti, AG, Marascio, N, Giancotti, A, Puccio, R, Liberto, MC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273881/ http://dx.doi.org/10.1186/cc14053

Ejemplares similares

Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2012)

Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients
por: Focà, A, et al.
Publicado: (2012)

Six years genotype distribution of Human Papillomavirus in Calabria Region, Southern Italy: a retrospective study
por: Galati, Luisa, et al.
Publicado: (2017)

Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region
por: Matera, Giovanni, et al.
Publicado: (2018)

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
por: Marascio, Nadia, et al.
Publicado: (2019)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study
por: Matera, Giovanni, et al.
Publicado: (2013)

Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series
por: Mazzitelli, Maria, et al.
Publicado: (2018)

Evaluation of a soluble CD14 subtype in patients with surgical sepsis
por: Fukui, Y
Publicado: (2012)

Update on different aspects of HCV variability: focus on NS5B polymerase
por: Marascio, Nadia, et al.
Publicado: (2014)

Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection
por: Marascio, Nadia, et al.
Publicado: (2023)

Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021)

Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals
por: Strazzulla, Alessio, et al.
Publicado: (2014)

Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry
por: Quirino, Angela, et al.
Publicado: (2014)

Identification of sepsis subtypes in critically ill adults using gene expression profiling
por: Maslove, David M, et al.
Publicado: (2012)

Gut Inflammation and Immunity: What Is the Role of the Human Gut Virome?
por: Focà, Alfredo, et al.
Publicado: (2015)

Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis
por: Sato, Masayuki, et al.
Publicado: (2015)

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial
por: Masson, Serge, et al.
Publicado: (2014)

Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis
por: van Maldeghem, Iris, et al.
Publicado: (2019)

Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates
por: Pugni, Lorenza, et al.
Publicado: (2015)

Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients
por: Klouche, Kada, et al.
Publicado: (2016)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial
por: Pietrasanta, Carlo, et al.
Publicado: (2021)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients
por: Kashiha, Arefeh, et al.
Publicado: (2018)

Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience
por: Quirino, Angela, et al.
Publicado: (2022)

Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study
por: Fiorentino, Teresa Vanessa, et al.
Publicado: (2018)

Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model
por: Nakamura, M, et al.
Publicado: (2008)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)

Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients
por: Marascio, Nadia, et al.
Publicado: (2016)

Hypomagnesemia in Critically Ill Sepsis Patients
por: Velissaris, Dimitrios, et al.
Publicado: (2015)

Soluble neprilysin and survival in critically ill patients
por: Lenz, Max, et al.
Publicado: (2022)

Relationship between reduced albumin and inflammation in the critically ill
por: Marano, Marco
Publicado: (2015)

Differential Gene Expression in Circulating CD14(+) Monocytes Indicates the Prognosis of Critically Ill Patients with Sepsis
por: Liepelt, Anke, et al.
Publicado: (2020)

Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment
por: Behnes, Michael, et al.
Publicado: (2014)

Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2021)

Impact of Obesity in Critical Illness
por: Anderson, Michaela R., et al.
Publicado: (2021)

Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
por: Liberto, Maria Carla, et al.
Publicado: (2022)

Hypocholesterolemia in sepsis and critically ill or injured patients
por: Wilson, Robert F, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_a9carua4chijbg1ikgoid4imip